You have 9 free searches left this month | for more free features.

Multiple Sclerosis, MS, CNS, Daclizumab

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Multiple Sclerosis (MS) Trial in Birmingham (Physical activity behavioral intervention in persons newly diagnosed with MS)

Recruiting
  • Multiple Sclerosis (MS)
  • Physical activity behavioral intervention in persons newly diagnosed with MS
  • Birmingham, Alabama
    University of Alabama at Birmingham
Jan 24, 2023

Multiple Sclerosis Trial in San Francisco, Cleveland (Multiple Sclerosis Clinical Care Delivery via telehealth, Multiple

Not yet recruiting
  • Multiple Sclerosis
  • Multiple Sclerosis Clinical Care Delivery via telehealth
  • Multiple Sclerosis Clinical Care Delivery via standard in clinic visits
  • San Francisco, California
  • +1 more
Jan 3, 2023

MS Using a Mobile Application

Enrolling by invitation
  • Multiple Sclerosis
  • BeCare Mobile App
  • New York, New York
    Weill Cornell Medical College
Dec 22, 2022

Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Secondary-progressive Multiple Sclerosis Trial in Belgium (Metformin

Not yet recruiting
  • Multiple Sclerosis
  • +2 more
  • Metformin Hydrochloride 850 mg Oral Tablet
  • Placebo
  • Brugge, Belgium
  • +4 more
May 30, 2023

Multiple Sclerosis Trial in Worldwide (MSCopilot® mobile application)

Not yet recruiting
  • Multiple Sclerosis
  • MSCopilot® mobile application
  • Oklahoma City, Oklahoma
  • +6 more
Apr 3, 2023

Multiple Sclerosis (MS), Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Primary Progressive Trial in San Francisco

Not yet recruiting
  • Multiple Sclerosis (MS)
  • +6 more
  • Clemastine Fumarate
  • Placebo
  • San Francisco, California
    Sandler Neurosciences Building, Neurological Clinical Research U
Jan 23, 2023

Multimodal Imaging Signatures of Biological Mechanisms

Not yet recruiting
  • Multiple Sclerosis (MS)
  • MRI
  • (no location specified)
Jan 12, 2023

End of Dose Phenomena in Subcutaneous Natalizumab Treated

Not yet recruiting
  • Multiple Sclerosis
  • (no location specified)
Jan 18, 2023

Multiple Sclerosis, Balance, Cognitive Impairment Trial in Roma (Technological rehabilitation)

Not yet recruiting
  • Multiple Sclerosis
  • +2 more
  • Technological rehabilitation
  • Roma, RM, Italy
    Fondazione Policlinico Universitario A. Gemelli IRCCS
Aug 10, 2023

Multiple Sclerosis Trial in Boston (Truvada (tenofovir/emtricitabine))

Enrolling by invitation
  • Multiple Sclerosis
  • Truvada (tenofovir/emtricitabine)
  • Boston, Massachusetts
    Massachusetts General Hospital
Jul 14, 2023

Long-Term Safety of Vumerity and Tecfidera in Multiple Sclerosis

Not yet recruiting
  • Multiple Sclerosis
  • Diroximel Fumarate
  • +2 more
  • (no location specified)
Mar 2, 2023

Multiple Sclerosis Fatigue Trial (Ketamine, Midazolam)

Recruiting
  • Multiple Sclerosis Fatigue
  • Baltimore, Maryland
    Johns Hopkins University
Jan 4, 2023

Multiple Sclerosis Trial in Chicago (Exercise Training Program, Flexibility Program)

Not yet recruiting
  • Multiple Sclerosis
  • Exercise Training Program
  • Flexibility Program
  • Chicago, Illinois
    University of Illinois at Chicago
Aug 9, 2023

Multiple Sclerosis Trial in Samsun (psychotherapeutic intervention)

Not yet recruiting
  • Multiple Sclerosis
  • psychotherapeutic intervention
  • Samsun, Turkey
    SAMSUN
Apr 24, 2023

Multiple Sclerosis Trial in New York (Active tDCS, Sham () stimulation)

Recruiting
  • Multiple Sclerosis
  • Active tDCS
  • Sham (placebo) stimulation
  • New York, New York
    New York University School of Medicine
Dec 28, 2022

Multiple Sclerosis Trial (Cognitive training, Motor training)

Recruiting
  • Multiple Sclerosis
  • Cognitive training
  • Motor training
  • Brussel, Belgium
  • +1 more
Nov 4, 2022

Magnetic Resonance Imaging to Evaluate Activity of Multiple

Recruiting
  • Multiple Sclerosis
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 30, 2023

    MS (Multiple Sclerosis) Trial in Bursa (Deep sensory assisted rehabilitation, classical rehabilitation)

    Active, not recruiting
    • MS (Multiple Sclerosis)
    • Deep sensory assisted rehabilitation
    • classical rehabilitation
    • Bursa, Yildirim, Turkey
    • +1 more
    Aug 7, 2023

    Multiple Sclerosis Trial in Bordeaux (Anti-Mullerian hormone (AMH) level, Antral follicle count (AFC), Clinical assessment)

    Not yet recruiting
    • Multiple Sclerosis
    • Anti-Mullerian hormone (AMH) level
    • +2 more
    • Bordeaux, France
      CHU de Bordeaux - service de neurologie
    Mar 6, 2023

    Immunoglobulin DeficiencyTreatable Cause of Fatigue in Multiple

    Recruiting
    • Hypogammaglobulinemia
    • +2 more
    • Laboratory test
    • Bern, BE, Switzerland
      University Hospital of Bern Inselspital
    Sep 26, 2022

    The MS-LINK™ Outcomes Study

    Recruiting
    • Multiple Sclerosis
      • Birmingham, Alabama
      • +5 more
      Nov 17, 2022

      Neurogenic Bladder, Multiple Sclerosis, Voiding Dysfunction Trial in Houston (Magstim Rapid2 System)

      Recruiting
      • Neurogenic Bladder
      • +2 more
      • Magstim Rapid2 System
      • Houston, Texas
        Houston Methodist Hospital
      Oct 3, 2023

      Multiple Sclerosis Trial in Amsterdam (Strenghtening the brain, Strengthening the mind)

      Recruiting
      • Multiple Sclerosis
      • Strenghtening the brain
      • Strengthening the mind
      • Amsterdam, Netherlands
        Amsterdam University Medical Centers, location VUmc
      Oct 10, 2023

      Older Adults, Multiple Sclerosis, Cognitive Impairment Trial in Chicago (Aerobic and Resistance Exercise Program (GEMS program),

      Recruiting
      • Older Adults
      • +3 more
      • Aerobic and Resistance Exercise Program (GEMS program)
      • Flexibility and Stretching Program (FLEX-MS program)
      • Chicago, Illinois
        University of Illinois at Chicago
      Jul 5, 2023

      Turkish Version of F-2-MS

      Not yet recruiting
      • Cultural Adaptation
      • +4 more
      • Cultural adaptation, reliability and validity
      • (no location specified)
      Oct 19, 2022